• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • May 2021 China Regulatory Round-up for Medical Devices

May 2021 China Regulatory Round-up for Medical Devices

Friday, 28 May 2021 / Published in Medical Device, NMPA Registration in China

May 2021 China Regulatory Round-up for Medical Devices

The NMPA (National Medical Products Administration) announced plans to write 5 new technical guidelines whilst there were 4 guidelines implemented and 6 drafts issued to solicitate for public comments.

On April 16, 2021, the Center for Medical Device Standardization Administration of the NMPA (National Medical Products Administration) issued the drafts of 4 regulatory guidelines:

  • Guidelines for the Classification of Radio Frequency Beauty Products (Draft)
  • Guidelines for the Classification of Artificial Intelligence Medical Software Products (Draft)
  • Guidelines for the Classification of Sports Rehabilitation Training Products (Draft)
  • Guidelines for the Classification of Drug-Device Combination Products (Draft)

In April and May, the CMDE (Center for Medical Device Evaluation) of the NMPA announced their plans to write the following technical guidelines:

Date of AnnouncementName of Technical Guidelines
April 28, 2021Technical Guidelines of Epstein-Barr Virus (EBV) Test Reagents  
April 28, 2021Technical Guidelines of Hepatitis E Virus (HEV) IgG/IgM Antibody Tests  
April 28, 2021Technical Guideline for the Development of Reference Intervals (RI)  
April 30, 2021Technical Guidelines of Additive Manufacturing on Polyether ether ketone (PEEK) Implants  
May 7, 2021Technical Guidelines for the Clinical Evaluation of Products with Oral Navigation System Applications

On May 7, 2021, the CMDE of the NMPA also issued the drafts of the following technical guidelines:

  • Technical Guidelines for Microcatheters
  • Technical Guidelines for Intraocular Lens

On May 8, the NMPA announced the implementation of the following technical guidelines:

  • Technical Guidelines for Dental Glass Ionomer Cement
  • Technical Guidelines for Citric Acid Disinfectants
  • Technical Guidelines for Single Use Pen Needles
  • Technical Guidelines for Disposable Sterile Ligating Clips

By Jacky Li. Contact Cisema if you would like to learn more.

What you can read next

New Details on Sampling Inspections of Medical Devices
Draft Regulation for Drug-Device Combination Product Registration in China
Marketing Authorization Holder (MAH)

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.